3. Results
tonsillopharyngitis
TONSILLOPHARYNGITIS
This phase IV study aimed to generate new clinical data about the speed of relief provided by a single application of Tantum Verde oromucosal spray (benzydamine HCl 0.3%) or Tantum Verde lozenges (benzydamine HCl 3 mg).A total of 363 adult patients with recent onset of ST (≤3 days) and a confirmed diagnosis of tonsillopharyngitis were randomized to benzydamine HCl 0.3% spray, (n = 181) or benzydamine HCl 3mg lozenges (n = 182) (Fig. Patients disposition in BePaiR study.